Revenue cycle · Clinical documentation integrity AI
SmarterDx
SmarterDx provides clinical documentation integrity AI that reviews charts after the encounter to find missed diagnoses, specificity gaps, and denial risk for health-system CDI and coding teams. It is not an ambient scribe.
Strong fit
- Health systems that want AI to find missed documentation and coding gaps after the chart is written
- Billing accuracy leaders comparing clinical AI documentation tools with only adding documentation review staff
- Buyers that need measurable denial prevention and fuller capture of patient severity, not another AI scribe
Weak fit
- Small outpatient clinics that only need visit coding for a handful of physicians
- Teams shopping for AI scribes to write notes rather than documentation review after the visit
- Groups that refuse cloud clinical AI on EHR data
Bottom line
SmarterDx is worth using for health systems that chart in a major EHR and still miss diagnoses and documentation detail that affect payment. It reviews documentation after the encounter rather than writing the note. Groups that want autonomous coding for professional fees may prefer Nym, and audit programs should look at MDaudit.
Score breakdown
Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.
SmarterDx is a clinical AI company in New York founded by physician CEO Michael Gao. It has a few hundred employees after a growth investment from New Mountain Capital.
Its platform reviews inpatient and related documentation after the chart is written. It flags missed diagnoses, missing detail, and denial risk for documentation and coding teams.
It does not write the note for the clinician, and it is not an AI scribe or a patient billing portal.
SmarterDx says customers recover millions of dollars a year and see strong returns compared with only adding documentation staff.
Setup is an EHR data and documentation workflow project, not a weekend install. Prices are quoted for each customer and, as with most large clinical AI tools, are not very clear.
Among the billing accuracy tools we review, SmarterDx scores highest. It beats autonomous coding tools when the need is complete inpatient documentation rather than code suggestions for professional fees.
Nym suits autonomous coding for professional fees, and Aptarro suits AI across claims workflows. MDaudit suits audit and compliance rather than capturing documentation during the stay.
Competitor landscape
| Vendor | Overall | Ease of implementation |
|---|---|---|
| SmarterDx | 7.6 | 7.2 |
| CodaMetrix | 7.6 | 7.3 |
| Fathom | 7.5 | 7.2 |
| Charta Health | 7.5 | 7.5 |
| MDaudit | 7.4 | 7.1 |
| Arintra | 7.2 | 7.1 |
| Maverick Medical AI | 7.2 | 7.1 |
| Nym | 6.6 | 6.4 |
Pricing
| Item | Detail |
|---|---|
| Model | Clinical documentation and payment recovery AI software for health systems, priced by quote. |
| What usually drives cost | Facility volume, modules (documentation review, coding help, denials), EHR integration scope, and support level. |
| What to ask before you buy | Expected yearly contract cost at your discharge volume, including setup and ongoing documentation review support. |
| Published pricing | SmarterDx does not publish prices. Every customer gets a quote. |
Prerequisites for purchase
| Need | Why it matters |
|---|---|
| What you need to get SmarterDx to function | |
| Named owners for documentation review and coding | AI findings go nowhere without reviewers. |
| EHR data access defined | No data feed means no recommendations. |
| Starting denial rates and case mix index | You cannot show a return without a starting point. |
| Privacy and business associate review done | Clinical AI stalls in security review. |
| A physician advisor to settle disputes | Coders alone cannot settle clinical disagreements. |
| What will maximize your value | |
| Start with one service line | Launching everywhere on day one multiplies the noise. |
| Measure money recovered at 90 days | This shows whether documentation review helps. |
| Drop overlapping review tools used during the stay | Duplicate lists confuse staff. |
| Deal-breakers | |
| You only need an AI scribe | |
| You allow no EHR data sharing | |
| No one can own documentation review | |
Value creation time frame
| # | Stage | Typical range |
|---|---|---|
| 1 | Security review and data mapping | 4-8 weeks |
| 2 | Test in one department | 6-12 weeks |
| 3 | Expand and adjust | 8-16 weeks |
Leadership
Methodology
| Weight | Factor | What it measures |
|---|---|---|
| 35% | Customer outcomes | Whether buyers get measurable operational or clinical-workflow results after go-live |
| 30% | Product | Capability depth, reliability, and fit for the job the category buys |
| 20% | Implementation | How hard it is to stand up, integrate, train, and stabilize |
| 15% | Pricing clarity | Whether a buyer can model total cost without a mystery quote |
| Label | Meaning |
|---|---|
| Highly recommend | Strong outcomes and product with manageable caveats |
| Recommend | Solid fit for the right buyer; know the tradeoffs |
| Conditional | Only with a specific use case or heavy caveats |
| Not recommended | Avoid for most buyers in this category |
Read our full methodology for how we weight scores and assign recommend labels.